C

Cell Biotech Co Ltd
KOSDAQ:049960

Watchlist Manager
Cell Biotech Co Ltd
KOSDAQ:049960
Watchlist
Price: 13 670 KRW -0.22% Market Closed
Market Cap: 93.6B KRW

Wall Street
Price Targets

Price Targets Summary
Cell Biotech Co Ltd

There are no price targets for Cell Biotech Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Cell Biotech Co Ltd Competitors:
Price Targets
300676
BGI Genomics Co Ltd
28% Upside
ENTA
Enanta Pharmaceuticals Inc
16% Upside
9926
Akeso Inc
54% Upside
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
9% Upside
688278
Xiamen Amoytop Biotech Co Ltd
22% Upside
QURE
Uniqure NV
119% Upside
IDYA
IDEAYA Biosciences Inc
44% Upside
CAPR
Capricor Therapeutics Inc
75% Upside

Revenue
Forecast

Revenue Estimate
Cell Biotech Co Ltd

For the last 13 years the compound annual growth rate for Cell Biotech Co Ltd's revenue is 6%. The projected CAGR for the next 3 years is -2%.

6%
Past Growth
-2%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Cell Biotech Co Ltd

For the last 13 years the compound annual growth rate for Cell Biotech Co Ltd's operating income is 1%. The projected CAGR for the next 3 years is -5%.

1%
Past Growth
-5%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Cell Biotech Co Ltd

For the last 13 years the compound annual growth rate for Cell Biotech Co Ltd's net income is 9%. The projected CAGR for the next 3 years is -23%.

9%
Past Growth
-23%
Estimated Growth
Estimates Accuracy
0%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Cell Biotech Co Ltd's stock price target?
Not Available

Cell Biotech Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Cell Biotech Co Ltd's Revenue forecast?
Projected CAGR
-2%

For the last 13 years the compound annual growth rate for Cell Biotech Co Ltd's revenue is 6%. The projected CAGR for the next 3 years is -2%.

What is Cell Biotech Co Ltd's Operating Income forecast?
Projected CAGR
-5%

For the last 13 years the compound annual growth rate for Cell Biotech Co Ltd's operating income is 1%. The projected CAGR for the next 3 years is -5%.

What is Cell Biotech Co Ltd's Net Income forecast?
Projected CAGR
-23%

For the last 13 years the compound annual growth rate for Cell Biotech Co Ltd's net income is 9%. The projected CAGR for the next 3 years is -23%.

Back to Top